Starting to increase the numbers of people saved from the brink with intravenous relenza, so hopefully pressure is mounting on GSK to produce more intravenous relenza and hopefully approval to use it sooner in the more severe cases.
- Forums
- ASX - By Stock
- tamiflu resistance not the point here
Starting to increase the numbers of people saved from the brink...
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review